newsfilter
← Latest News
Earnings Call Transcripts·

2026 STIFEL VIRTUAL TARGETED ONCOLOGY FORUM - AN2 THERAPEUTICS INC

All right. Good afternoon, everyone. I'm Stephen Willey, one of the senior biotech analysts here at Stiefel, and glad to have with us as part of the next session, CEO of Antu Therapeutics, Eric Isom. Eric, thanks for joi

Company
AN2 THERAPEUTICS INC
Keywords
AN2 THERAPEUTICS INC